Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Status:
Completed
Trial end date:
2018-06-21
Target enrollment:
Participant gender:
Summary
A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical
Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical
product in Patients with Mild to Moderate Onychomycosis